Report 2018
Rethink Tomorrow
Report 2018

Board of Directors

Novozymes’ Board of Directors has seven members who are elected at the Annual Shareholders’ Meeting and three employee-elected members. The Board represents many years of global management experience, and the members’ competencies combine to ensure expert management of the company.

Jørgen Buhl Rasmussen

Born 1955. Chairman of the Board since 2017. Adjunct Professor at Copenhagen Business School, Denmark. Member of the Audit Committee and chairman of the Nomination and Remuneration Committee. Member of the Board since 2011. Elected for one year at a time.

Agnete Raaschou Nielsen

Born 1957. Vice Chairman of the Board since 2017. Member of the Audit Committee and of the Nomination and Remuneration Committee. Member of the Board since 2011. Elected for one year at a time.

Lars Green*

Born 1967. Executive Vice President, Business Services and Compliance, Novo Nordisk A/S. Chairman of the Audit Committee. Member of the Board since 2014. Elected for one year at a time.

Kasim Kutay*

Born 1965. CEO, Novo Holdings A/S. Member of the Board since 2017. Elected for one year at a time.

Patricia Malarkey

Born 1965. Member of the Board since 2018. Elected for one year at a time.

Kim Stratton

Born 1962. Member of the Nomination and Remuneration Committee. Member of the Board since 2017. Elected for one year at a time.

Mathias Uhlén

Born 1954. Professor at the Royal Institute of Technology (Sweden) and at the Technical University of Denmark (DTU). Member of the Board since 2007. Elected for one year at a time.

Lena Bech Holskov*

Born 1967. Employee representative. Safety Adviser. Member of the Board since 2013. Elected for four years at a time.

Anders Hentze Knudsen*

Born 1959. Employee representative. Senior Operator. Member of the Board since 2013. Elected for four years at a time.

Back to notes
Scroll to top